Sterling Bancorp Q2 EPS $(0.04) Down From $0.07 YoY

Sterling Bancorp (NASDAQ:SBT) reported quarterly losses of $(0.04) per share. This is a 157.14 percent decrease over earnings of $0.07 per share from the same period last year.

Sterling Bancorp (NASDAQ:SBT) reported quarterly losses of $(0.04) per share. This is a 157.14 percent decrease over earnings of $0.07 per share from the same period last year.

Total
0
Shares
Related Posts
Read More

FDA Accepted Submission of Supplemental New Drug Application for LYNPARZA in Combination With Abiraterone and Prednisone or Prednisolone for Patients With Metastatic Castration-Resistant Prostate Cancer and Grants Priority Review

AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that a supplemental New Drug Application (sNDA) for LYNPARZA in combination with abiraterone and prednisone or prednisolone has been accepted and granted priority review by the U.S.

AZN